(Total Views: 405)
Posted On: 10/16/2020 1:16:00 PM
Post# of 109

$REGN News Article - CHMP Recommends Approval of Dupixent (dupilumab) for Children Aged 6 to 11 Years with Severe Atopic Dermatitis https://marketwirenews.com/news-releases/chmp...35534.html


My Twitter: WhyteStocks